Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional Dose Yellow Fever Vaccination in Gambian Infants
PACTR202303893454050Phase 3Recruiting
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- May 2023
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of 17D yellow fever vaccine and measles vaccine, live attenuated + rubella vaccine, live attenuated in yellow fever (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Started May 2023; status: recruiting.
02
Drugs
17D yellow fever vaccinemeasles vaccine, live attenuated + rubella vaccine, live attenuated
03
Conditions
yellow fever
Beyond the preview
Go deeper on PACTR202303893454050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202303893454050.